A ransomware claim has been issued against Glenmark Pharmaceuticals (glenmarkpharma.com) in India, attributed to the threat actor incransom. Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, is a global company operating in over 25 countries with a strong focus on research and development. #India
Incident Details
- Victim: glenmarkpharma.com
- Sector: Healthcare
- Country: IN
- Actor: incransom
- Source: http://incblog6qu4y4mm4zvw5nrmue6qbwtgjsxpw6b7ixzssu36tsajldoad.onion/blog/disclosures/69c3d3d18f1d14b7437c320c
- Discovered: 2026-03-25 16:33:46.367560
- Published: 2026-03-25 15:00:00.000000
Information
- Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India
- Global pharmaceutical company that develops, manufactures, and markets pharmaceutical products
- Operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East
- Strong focus on research and development of innovative medications
- Specializes in various therapeutic areas and maintains a diverse portfolio serving both business and consumer markets worldwide
- Rajeev Sharma — Senior Vice President and Chief Financial Officer, North America
- Laura Lester — Senior Vice President & General Counsel, North America
- Jim Brown — Senior Vice President
- Firas B Abulaban — Senior Vice President and Corporate Quality Head, North America
- Bradley Nowels — Vice President Institutional Sales, North America
- Vishal Arora — Vice President of Business Development and Licensing
- Michael Pope — Executive Director and Site Head, Monroe, NC
- Adam Subervi — Chief Compliance Officer
- Fabio Moreno — Executive Director and Head of the OTC Business
- Kathleen (Kathy) McKenna — Senior Director, Human Resources
- Company Secretary & Compliance Officer — [email protected]; Tel: +91 22 4018 9999; Fax: +91 22 4018 9986
- Registrar and Share Transfer Agents: KFIN Technologies Limited, Selenium Building, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500032
- KFIN contact details: Email [email protected]; Toll Free/Phone: 1800 309 4001; WhatsApp: (91) 910 009 4099
- KFIN websites: Corporate – www.kfintech.com; RTA – https://ris.kfintech.com; Investor Support Centre (DIY) – https://ris.kfintech.com/clientservices/isc
- Business development inquiries: [email protected]
- Grievance Officer: [email protected]; Tel: +91 22 4018 9999; Fax: +91 22 4018 9986
Disclaimer: This post is based on public claims made by the ransomware group "incransom". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.